Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Phase II Study of Gemcitabine Plus Platinum Salt in Combination With Bevacizumab (Avastin®) for Metastatic Collecting Duct Carcinoma

NCT02363751 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT02363751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02363751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Phase II Study of Gemcitabine Plus Platinum Salt in Combination With Bevacizumab (Avastin®) for Metastatic Collecting Duct Carcinoma
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2014
Completion date
August 31, 2020
Enrollment
36 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

collecting duct carcinoma (kidney)